Tarsons Q1 FY27 revenue up 35% YoY but profit drops sharply

Revenue Growth 20pctEbitda Margin CompressionResults View source PDF Explain this filing

TARSONS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.8%Reaction day

₹313.90

prior close

₹290.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-4.6% vs market

Medical Equipment & Supplies peers, median of 10sector-0.7%-4.1% vs sector

On the reaction day the stock moved 4.6 pts less than Nifty Microcap 250 and 4.1 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.0

10m

+1.2

15m

+0.0

30m

+1.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.8-0.2-4.6-0.7-4.1

Next day

-1.0+0.2-1.2-2.0+1.0

-0.5+0.4-0.8-0.1-0.4

+18.2+0.4+17.8-0.2+18.4

+15.9+0.6+15.4-1.8+17.7

+7.7+0.9+6.7-2.8+10.4

+7.4+0.9+6.5-0.7+8.1

15d

+9.5+0.9+8.6-0.8+10.3

-0.8+2.3-3.1-2.7+1.9

+5.7-1.1+6.8-7.5+13.2

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 10Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 results: Consolidated revenue grew 35% YoY to Rs 1,102.42M; standalone revenue up 21% to Rs 861.47M. But profitability collapsed - consolidated PBT fell about 89% to Rs 3.24M and standalone PBT dropped to Rs 9.22M from Rs 47.78M. Depreciation jumped 42% and finance costs up 24% YoY, squeezing margins. 43rd AGM on September 24, 2026. Price Waterhouse issued unmodified review.

Likely market impact

Strong topline growth masks sharp profit decline as costs surge. Watch margin trends closely in coming quarters.